T cells emerged as the major producers of CCL5, a key CCR5 ligand, pointing to their role in the formation of the observed CD14+MMP9+/T cell immune aggregates characteristic of CLE and DM lesions. The gene discussed is CCR5; the disease is dermatomyositis.